KAUFMAN, MICHAEL D.,FLYNN, DANIEL L.,AHN, YU MI,VOGETI, LAKSHMINARAYANA,CALDWELL, TIMOTHY MALCOLM
申请号：
CA2903285
公开号：
CA2903285A1
申请日:
2014.03.14
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
Described are compounds of Formula I which find utility in the treatment of cancer, autoimmune diseases and metabolic bone disorders through inhibition of c-FMS (CSF-IR), c-KIT, and/or PDGFR kinases. These compounds also find utility in the treatment of other mammalian diseases mediated by c- FMS, c-KIT, or PDGFR kinases.
